Faculty of Health Sciences - News

Bisphosphonates are commonly used to treat, for example, ostoporosis. One approach to mitigate their side effects is to utilize controlled delivery and release systems.

Erkko Ylösmäki is the new CEO of Rokote Laboratories Finland, a research-based company developing a coronavirus vaccine. Clinical trials will start by the end of summer 2024 at the earliest.

The topic the PhD thesis is the study of miRNA genes and their cell-type-specific expression and transcriptional regulation.

A total of 1,403 higher education institutions took part in the sustainability ranking arranged by QS, and the UEF was ranked in 164th overall.

The University of Eastern Finland receives a total of 1.8 million euros in funding for infrastructure projects. UEF participates five funded consortiums.

The challenge has been launched by the UEF Cancer AI research team with the aim to develop an architecture capable of automatically estimating the breast percentage density from mammograms.

The results of the PhD study improve the understanding of molecular mechanisms underlying inflammasome activation in age-related macular degeneration and UV radiation-induced corneal inflammation.

Professor Jarkko Rautio was granted funding for an Academy Project called “Boosting delivery of LAT1-targeted boron carriers for improved boron neutron capture therapy”.

The University of Eastern Finland together with Karelia and Savonia Universities of Applied Sciences use the well-known education export brand in business-to-business marketing.

A total of 11 Finnish female scientists were ranked in the top 1,000.